tofacitinib,ustekinumab
janssen,pfizer
['ibd', 'tofa', 'tofacitinib', 'ulcerative colitis', 'ustekinumab']
in biologic-experienced patients with ulcerative colitis, tofacitinib and ustekinumab achieve about the same rate of corticosteroid-free remission by 16 weeks. #ddw2023 #ibd
No. 1–rated independent monthly newspaper providing news and information for 20,000+ gastroenterologists, colorectal surgeons, hepatologists, PAs and NPs.